We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenetic Drug Against Mantle Cell Lymphoma

News   Jun 12, 2018 | Original story from the Bellvitge Biomedical Research Institute (IDIBELL)

 
Epigenetic Drug Against Mantle Cell Lymphoma

These are cells of a patient with mantle lymphoma before (left image) and after (right image) of treatment with the drug. Inhibition of cell growth is observed. Credit: IDIBELL

 
 
 

RELATED ARTICLES

Strategy Could Help Treat Behavioral Abnormalities Linked to Autism

News

Researchers report in Nature Medicine a potential new treatment strategy for autism spectrum disorder – for which many cases are linked to mutated PTEN. Now, using Pten-deficient mice, researchers discover that a previously unexplored pathway goes “awry” in the brain, and by “rescuing” this pathway, it is possible to reverse behavioral and neurophysiological abnormalities.

READ MORE

Ranitidine Recalled Due to Potential Carcinogen Contamination

News

Teva UK Ltd is recalling unexpired stock of certain batches of two types of Ranitidine medicines – used to treat conditions such as heartburn and stomach ulcers.

READ MORE

International Alliance Aims To Detect the (Almost) Undetectable

News

A new transatlantic research alliance aims to develop radical new strategies and technologies to detect cancer at its earliest stage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE